Transparency in the Balance: The Case for Including Negative Trial Data in FDA Drug Labeling
The regulatory landscape for pharmaceuticals is built on a foundation of trust. Physicians, pharmacists, and patients rely on the Food and Drug Administration (FDA) to act as a rigorous filter,…










